{"transactions":[{"id":963012,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-18T18:24:02.000Z","date":"2025-12-16","kind":"other","planned":false,"acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units were issued to the Reporting Person on November 30, 2021 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan and the Restricted Stock Unit Agreement, subject to vesting upon the achievement of specified performance milestones. The applicable milestones were not achieved, and accordingly, the Reporting Person has agreed to voluntarily surrender and cancel the unvested Restricted Stock Units."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-25-028396","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315225028396/ownership.xml","form_type":"4"}},{"id":1323972,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-12-20T20:33:18.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2027."}],"balance_after":200000,"derivative":{"exercise_price":2.57,"expiration_date":"2034-12-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-24-051146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315224051146/ownership.xml","form_type":"4"}},{"id":1325217,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-19T21:51:33.000Z","date":"2024-12-19","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":2.55,"value":30600.0,"ownership":{"direct":true},"balance_after":222236,"source":{"system":"sec-edgar","filing":"0001493152-24-050865","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315224050865/ownership.xml","form_type":"4"}},{"id":1718977,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2023-12-07T17:05:52.000Z","date":"2023-12-05","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2026."}],"balance_after":300000,"derivative":{"exercise_price":3.59,"expiration_date":"2033-12-05","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-23-044055","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315223044055/ownership.xml","form_type":"4"}},{"id":2220067,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-28T16:05:47.000Z","date":"2022-06-27","kind":"purchase","acquired":true,"shares":2500,"price":3.8,"value":9500.0,"ownership":{"direct":true},"balance_after":210236,"source":{"system":"sec-edgar","filing":"0001493152-22-017957","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315222017957/ownership.xml","form_type":"4"}},{"id":2488442,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2021-12-02T18:27:58.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":349781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2024."}],"balance_after":349781,"derivative":{"exercise_price":6.7,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":349781},"source":{"system":"sec-edgar","filing":"0001493152-21-030335","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315221030335/ownership.xml","form_type":"4"}},{"id":2488441,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-02T18:27:58.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted 200,000 restricted stock units on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The restricted stock units are subject to milestone-based vesting as follows: (i) 50% upon SAVVE (Surgical Anti-reflux Venous Valve Endoprosthesis) endpoints being achieved, and (ii) 50% upon the Pre-Market Approval of the VenoValve."}],"balance_after":207736,"source":{"system":"sec-edgar","filing":"0001493152-21-030335","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315221030335/ownership.xml","form_type":"4"}},{"id":2502469,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-11-19T17:27:48.000Z","date":"2021-11-19","kind":"purchase","acquired":true,"shares":2000,"price":7.43,"value":14860.0,"ownership":{"direct":true},"balance_after":7736,"source":{"system":"sec-edgar","filing":"0001493152-21-029430","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315221029430/ownership.xml","form_type":"4"}},{"id":2504563,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-11-18T16:24:11.000Z","date":"2021-11-16","kind":"purchase","acquired":true,"shares":2000,"price":7.87,"value":15740.0,"ownership":{"direct":true},"balance_after":5736,"source":{"system":"sec-edgar","filing":"0001493152-21-029229","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315221029229/ownership.xml","form_type":"4"}},{"id":2705157,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.00001 par value","published_at":"2021-05-19T20:20:49.000Z","date":"2021-05-18","kind":"purchase","acquired":true,"shares":3000,"price":5.47,"value":16410.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person acquired these shares of common stock on the open market."}],"balance_after":3736,"source":{"system":"sec-edgar","filing":"0001493152-21-012298","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315221012298/ownership.xml","form_type":"4"}},{"id":2842962,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2021-02-22T21:56:49.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":838000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest in equal quarterly installments over a two a year period, however the stock options may only become exercisable following receipt by the registrant of stockholder approval to increase the size of the Plan sufficiently to permit the exercise in full of such stock options under the Plan. If the registrant's stockholders do not approve an increase in the size of the Plan, the options will be void."}],"balance_after":838000,"derivative":{"exercise_price":8.2,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":838000},"source":{"system":"sec-edgar","filing":"0001493152-21-004530","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315221004530/ownership.xml","form_type":"4"}},{"id":3078658,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2020-07-21T21:55:56.000Z","date":"2020-07-18","kind":"grant","acquired":true,"shares":1080207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The common stock options were issued, and vested upon grant."}],"balance_after":1080207,"derivative":{"exercise_price":0.4,"expiration_date":"2030-07-18","underlying":"Common Stock","underlying_shares":1080207},"source":{"system":"sec-edgar","filing":"0001493152-20-013751","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315220013751/ownership.xml","form_type":"4"}},{"id":3078657,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2020-07-21T21:55:56.000Z","date":"2020-07-18","kind":"other","acquired":false,"shares":1080207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Board terminated the common stock options pursuant to Section 17.15 of the Amended and Restated 2016 Omnibus Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":4.99,"exercise_date":"2018-04-26","expiration_date":"2028-04-26","underlying":"Common Stock","underlying_shares":1080207},"source":{"system":"sec-edgar","filing":"0001493152-20-013751","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315220013751/ownership.xml","form_type":"4"}},{"id":3078656,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2020-07-21T21:55:21.000Z","date":"2020-07-18","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on July 18, 2020. The award is subject to time-based vesting and will vest in equal monthly portions over three years."}],"balance_after":1000000,"derivative":{"exercise_price":0.4,"expiration_date":"2030-07-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-20-013748","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315220013748/ownership.xml","form_type":"4"}},{"id":3553490,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-04-17T18:47:28.000Z","date":"2019-03-12","kind":"purchase","acquired":true,"shares":18382,"price":1.36,"value":24999.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person purchased the shares of common stock in the Registrant's private placement transaction that closed on March 12, 2019."},{"field":"security","element":"securityTitle","label":"F2","text":"The reporting person's original Form 4 included the incorrect number of shares purchased in the private placement and the incorrect price per share paid by the reporting person in the private placement."}],"balance_after":18382,"source":{"system":"sec-edgar","filing":"0001493152-19-005579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315219005579/ownership.xml","form_type":"4/A","original_submission_date":"2019-03-14"}},{"id":3595231,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-03-14T18:52:31.000Z","date":"2019-03-12","kind":"purchase","acquired":true,"shares":21740,"price":1.15,"value":25001.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person purchased the shares of common stock in the Registrant's private placement transaction that closed on March 12, 2019."}],"balance_after":21740,"source":{"system":"sec-edgar","filing":"0001493152-19-003384","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315219003384/ownership.xml","form_type":"4"}},{"id":3807145,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-26T15:25:58.000Z","date":"2018-09-24","kind":"grant","acquired":true,"shares":1080207,"price":2.71,"value":2927360.97,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 24, 2018, the Board of Directors of the Company approved the grant of a ten-year option to purchase an aggregate of 1,080,207 shares of the Company's common stock at an exercise price of $4.99 per share (the \"Option\") to the reporting person, which Option was issued pursuant to the terms of that certain employment agreement, dated March 30, 2018 (the \"Effective Date\"), between the reporting person and the Company (the \"Employment Agreement\"). The grant of the Option was in fulfillment of the express terms of the previously agreed to Employment Agreement, which was filed as an exhibit to the Company's Form S-1/A with the Securities and Exchange Commission on April 16, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Employment Agreement provides that the reporting person is entitled to receive an equity grant of an option to purchase up to 6.5% of the Company's common stock outstanding on a fully diluted basis at the closing of the Company's initial public offering. The shares subject to the Option will vest over a period of 2 years, with 1/5th of the shares subject to the Option having vested on the Effective Date (the \"Initial Vesting\") and the remaining shares vesting in substantially equal monthly installments during the twenty-four (24) month period following the Effective Date and ending March 30, 2020 (as of the date of this report 396,076 shares subject to the Option, including the Initial Vesting, have vested)."}],"balance_after":1080207,"derivative":{"exercise_price":4.99,"expiration_date":"2028-09-24","underlying":"Common Stock","underlying_shares":1080207},"source":{"system":"sec-edgar","filing":"0001493152-18-013747","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315218013747/ownership.xml","form_type":"4"}},{"id":4294536,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-06-05T10:52:14.000Z","date":"2017-06-02","kind":"purchase","acquired":true,"shares":9900,"price":0.88,"value":8712.0,"ownership":{"direct":true},"balance_after":61553,"source":{"system":"sec-edgar","filing":"0001513162-17-000183","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000183/primary_doc.xml","form_type":"4"}},{"id":4294535,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-06-05T10:52:14.000Z","date":"2017-06-02","kind":"purchase","acquired":true,"shares":100,"price":0.85,"value":85.0,"ownership":{"direct":true},"balance_after":51653,"source":{"system":"sec-edgar","filing":"0001513162-17-000183","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000183/primary_doc.xml","form_type":"4"}},{"id":4363742,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Subscription Right","published_at":"2017-04-04T19:56:01.000Z","date":"2017-04-03","kind":"other","acquired":false,"shares":5995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"ITUS Corporation distributed to holders of its common stock and certain warrants, non-transferrable subscription rights to purchase one share of common stock for each share of common stock held on March 1, 2017. The rights offering expired on March 24, 2017, but the company did not close the rights offering until April 3, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"ITUS Corporation distributed to holders of its common stock and certain warrants, non-transferrable subscription rights to purchase one share of common stock for each share of common stock held on March 1, 2017. The rights offering expired on March 24, 2017, but the company did not close the rights offering until April 3, 2017."}],"balance_after":0,"derivative":{"exercise_price":2.38,"exercise_date":"2017-03-03","underlying":"Common Stock","underlying_shares":5995},"source":{"system":"sec-edgar","filing":"0001513162-17-000104","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000104/primary_doc.xml","form_type":"4"}},{"id":4363741,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-04-04T19:56:01.000Z","date":"2017-04-03","kind":"other","acquired":true,"shares":5995,"price":2.38,"value":14268.1,"ownership":{"direct":true},"balance_after":51553,"source":{"system":"sec-edgar","filing":"0001513162-17-000104","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000104/primary_doc.xml","form_type":"4"}}]}